These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Reference pricing system for triptans: Chaos in the pharmac]. Diener HC Med Monatsschr Pharm; 2010 Dec; 33(12):451. PubMed ID: 21189519 [No Abstract] [Full Text] [Related]
5. Prescription Patterns and the Cost of Migraine Treatments in German General and Neurological Practices. Jacob L; Kostev K Pain Pract; 2017 Jul; 17(6):747-752. PubMed ID: 27622427 [TBL] [Abstract][Full Text] [Related]
6. Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy. Kelman L; Von Seggern RL Am J Ther; 2006; 13(5):411-7. PubMed ID: 16988536 [TBL] [Abstract][Full Text] [Related]
7. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination. Cady RK; Banks J; Jones BA; Campbell J Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164 [TBL] [Abstract][Full Text] [Related]
8. [Therapy and prophylaxis of migraine]. Hoffmann J; Reuter U MMW Fortschr Med; 2009 Apr; 151(14):114-7; quiz 118. PubMed ID: 19504851 [No Abstract] [Full Text] [Related]
9. Triptans for Acute Migraine: A Drug Class Review. Purdy RA Headache; 2015; 55(7):921-2. PubMed ID: 26140662 [No Abstract] [Full Text] [Related]
10. [Acute migraine medications and evolution from episodic to chronic migraine]. Haag G MMW Fortschr Med; 2009 Feb; 151(6):41, 43. PubMed ID: 19432251 [No Abstract] [Full Text] [Related]
11. Drug safety in acute migraine treatment. Tajti J; Majláth Z; Szok D; Csáti A; Vécsei L Expert Opin Drug Saf; 2015 Jun; 14(6):891-909. PubMed ID: 25773005 [TBL] [Abstract][Full Text] [Related]
12. [Due to cost considerations too few triptans are prescribed]. Diener HC MMW Fortschr Med; 2006 Apr; 148(16):63. PubMed ID: 16688955 [No Abstract] [Full Text] [Related]
13. [Utilizing the strength(s) of rizatriptan 10 mg: cost effective against migraine attacks]. MMW Fortschr Med; 2009 Mar; 151(13):92-3. PubMed ID: 19504831 [No Abstract] [Full Text] [Related]
14. [Current pharmacotherapy in migraine]. Csépány É; Magyar M; Gyüre T; Bozsik G; Ertsey C Neuropsychopharmacol Hung; 2015 Dec; 17(4):169-76. PubMed ID: 26727720 [TBL] [Abstract][Full Text] [Related]
15. Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment. Tfelt-Hansen P Headache; 2008 Apr; 48(4):601-5. PubMed ID: 18377382 [TBL] [Abstract][Full Text] [Related]
17. [50.000 Danes are at risk of developing drug-induced headache]. Bülow-Olsen A Ugeskr Laeger; 2013 Aug; 175(34):1901. PubMed ID: 26491731 [No Abstract] [Full Text] [Related]
18. [Therapy and prophylaxis of migraine]. Diener HC; Rabe K MMW Fortschr Med; 2012 Apr; 154(7):52-5. PubMed ID: 22558876 [No Abstract] [Full Text] [Related]